Acceleron Pulmonary Arterial Hypertension R&D Day

New York, November 16, 2018

Please join key opinion leaders and the XLRN team to discuss an R&D deep dive for Pulmonary Arterial Hypertension next Friday in NYC.

Friday, November 16, 2018

8:30am - Registration & Breakfast
9:00am - 12:00pm - Presentations

The Maxwell
Great Room 1
541 Lexington Ave, New York

For more information or to RSVP, contact

RSVP for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

Acceleron Pharma Inc [XLRN] US$2,215 MM MCap
Lead ther­a­peu­tic can­di­date in he­ma­tol­o­gy, lus­pa­ter­cept, un­der a glob­al part­n­er­ship with Cel­gene, re­port­ed pos­i­tive Phase 3 ME­DAL­IST and BE­LIEVE trial re­sults, and cont­in­ues to ad­vance mul­ti­ple Ph2 and Ph3 trials for the treat­ment of chron­ic ane­mia in myelodys­plas­tic syn­dromes, be­ta-tha­lassemia, and myelo­fi­bro­sis. [more in­for­ma­tion]